Related Experiment Videos
Clozapine reduces violence and persistent aggression in schizophrenia
1Department of Psychiatry, Harvard Medical School, and Massachusetts General Hospital, Boston, USA.
The Journal of Clinical Psychiatry
|April 16, 1998
Summary
Clozapine effectively reduces violence and aggression in individuals with treatment-resistant schizophrenia. This improved symptom control can aid community reintegration and reduce societal costs associated with severe mental illness.
Area of Science:
- Psychiatry
- Neuroscience
- Pharmacology
Background:
- Violence and aggression are significant issues in the general population and psychiatric patients.
- Schizophrenia is strongly associated with violence and aggression, often linked to suicidal ideation and substance abuse.
- Current treatments for pathological aggression, especially in treatment-resistant schizophrenia, are often trial-and-error and associated with side effects.
Purpose of the Study:
- To review the evidence for clozapine's efficacy in treating aggression and violence.
- To evaluate clozapine as a treatment option for treatment-refractory patients with schizophrenia exhibiting aggression.
Main Methods:
- Review of existing evidence on clozapine's impact on aggression and violence.
- Focus on patients with treatment-refractory schizophrenia.
Main Results:
- Clozapine demonstrates efficacy in reducing violence and persistent aggression.
- This reduction is particularly noted in patients with treatment-refractory schizophrenia.
Conclusions:
- Clozapine treatment can significantly decrease aggression and violence in schizophrenia patients.
- Successful management of aggression with clozapine may facilitate community integration and offer societal cost savings.